Browse drugs

…urable antitumor responses. However, clinical response rates to PD-1/PD-L1 inhibitors remain limited, particularly in immunologically “cold” tumors s…

…ment that may be antagonized with immune checkpoint inhibition. VSIG4, which is exclusively expressed on macrophages, may be a potent…